| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bio-Techne Corp (TECH) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. TECH is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 124.1K | $5.57M | - | |
| CEO | 61.7K | $2.77M | - | |
| Dir | 46.5K | $2.09M | - | |
| Dir | 44.6K | $2.00M | - | |
| Dir | 15.4K | $691.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2017 | Lucas Roger C | Director | Sell | 100 | $102.60 | $10,260.00 | -2.6% | |
| Jan 10, 2017 | Lucas Roger C | Director | Sell | 100 | $103.57 | $10,357.00 | -2.5% | |
| Dec 9, 2016 | Lucas Roger C | Director | Sell | 100 | $108.92 | $10,892.48 | -2.5% | |
| Nov 29, 2016 | Holbrook Karen A | Director | Sell | 1,000 | $106.73 | $106,733.00 | -33.6% | |
| Nov 16, 2016 | Lucas Roger C | Director | Sell | 100 | $105.75 | $10,575.00 | -2.4% | |
| Oct 19, 2016 | Lucas Roger C | Director | Sell | 100 | $104.71 | $10,471.00 | -3.0% | |
| Sep 21, 2016 | Lucas Roger C | Director | Sell | 100 | $108.91 | $10,891.00 | -2.9% | |
| Sep 8, 2016 | Gould Kevin S | SVP Clinical Controls | Sell | 524 | $110.50 | $57,903.57 | -23.9% | |
| Sep 8, 2016 | Higgins John L66 | Director | Sell | 1,700 | $109.83 | $186,715.93 | -55.6% | |
| Sep 2, 2016 | Baumgartner Robert V52 | Director | Sale+OE | 6,467 | $107.17 | $693,039.06 | -34.8% |